biocryst nasdaq realtime
Der Sprung zu wöchentlichen Höchstständen von 4 US-Dollar. A number of other equities analysts also recently weighed in on the company. Type a symbol or company name. What Stifel Thinks, Cardano News: Coinbase Pro Adding ADA, 9 Things to Know Before Trading Begins March 18, The Week's Top Stories: Fed Effect, AstraZeneca, and March Madness, Professional Cornhole Makes Its Sports Betting Debut on DraftKings, SAFE Banking Act for Cannabis Industry Reintroduced in House, Forget AMC and Gamestop: These 2 Popular Robinhood Stocks Are Better Buys, Lit Markets Provide Price Improvement Too, data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX — FREE, Top 25 Broker Analyst Picks of the S&P 500, Analyst target price data provided by Zacks Investment Research via Quandl.com, Get the latest Zacks research report on BCRX - FREE, Do Not Sell My Personal Information (CA Residents Only). Click here now. 14/03/2021 04:07:02 1 … BioCryst Pharmaceuticals, Inc. Common Stock, Do Not Sell My Personal Information (CA Residents Only). The biotechnology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.09). At Stock Options Channel, our … The MarketWatch News Department was not involved in the creation of this content. BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th. Auf – – 2020 (Montag) Aktien von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) ergab einen Unterschied von 8. The all time high for this statistics is 25. Real time BioCryst Pharmaceuticals (BCRX) stock price quote, stock graph, news & analysis. 58% zum Tageskurs der Aktie. The Top 25 Broker Analyst Picks of the S&P 500 ». Copy and paste multiple symbols separated by spaces. Aktuelle Aktienkurse der BIOCRYST PHARMACEUTICALS INC, Börsenkurs 10,66 -6,61 %, Tief 10,660, Hoch 12,025 lll BioCryst Pharmaceuticals Chart Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) - BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a … -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. Technical analysis gauges display real-time ratings for the selected timeframes. BIOCRYST PHARM (896047 | US09058V1035): Alle Börsen- und Handelsplätze mit aktuellen Kursen im Überblick. BioCryst Pharmaceuticals (BCRX) share price, charts, trades & the UK's most popular discussion forums. Create your Watchlist to save your favorite quotes on Nasdaq.com. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will host a virtual R&D day on Monday, March 22, 2021 from 9:00 am to 11:00 am ET. A number of brokerages have recently issued … BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. BioCryst Pharmaceuticals, WKN: 896047, ISIN: US09058V1035 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen -0.31 (-2.39%) DATA AS OF Mar 12, 2021 12:00 PM ET. Add to Watchlist. Type a symbol or company name. Kursdaten & Kursvergleich der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de kostenlos, realtime oder verzögert. How has BioCryst Pharmaceuticals's share price performed over time and what events caused price changes? BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was in 26 hedge funds' portfolios at the end of June. At Stock Options Channel, our … When autocomplete results are available use up and down arrows to review and enter to select. Copy and paste multiple symbols separated by spaces. $11.40. Results are available at a quick glance. View real-time stock prices and stock quotes for a full financial overview. The biotechnology company reported ($0.34) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.25) by ($0.09). BidaskClub upgraded shares of BioCryst Pharmaceuticals (NASDAQ:BCRX) from a sell rating to a hold rating in a report issued on Wednesday morning, BidAskClub reports. -0.055 (-0.49%) CLOSED AT 4:00 PM ET ON Mar 08, 2021. Below is a table showing the current thinking of the analysts that cover BioCryst Pharmaceuticals Inc: The average rating presented in the last row of the above table above is from 1 to 5 where 1 is Strong Buy and 5 is Strong Sell. Handelsinformationen von BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) BCRX ist sofort grün, wie dies heute im Intraday-Handel mit Aktion 1 zu sehen ist. Data is currently not available. Create your Watchlist to save your favorite quotes on Nasdaq.com. BioCryst Aktie (BCRX) mit Realtime-Aktienkurs, Chart, Bilanzinformationen, Dividenden, historischen Daten, aktuellen News und Analysen. BioCryst to Host Virtual R&D Day on March 22, 2021 March 11, 2021 Early Access to BioCryst’s Berotralstat Granted for HAE Patients in France March 2, 2021 BioCryst Submits Marketing Authorization Application for UK Approval of ORLADEYO™ (berotralstat), an Oral, Once-daily Therapy to Prevent Attacks in Patients with Hereditary Angioedema $67.09. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. Touch device users, explore by touch or with swipe gestures. In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for … 80 M Aktien. $11.11. Needham & Company LLC reaffirmed a hold rating on shares of BioCryst Pharmaceuticals in a research report on Wednesday, November 6th. Instantly find out the BioCryst Pharmaceuticals, Inc. stock quote In recent trading, shares of BioCryst Pharmaceuticals Inc (Symbol: BCRX) have crossed above the average analyst 12-month target price of $11.78, changing hands for $12.07/share. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4). BNK Invest owns and operates a market news family of websites including DividendChannel, ETFChannel, StockOptionsChannel, and others, which make up an investor community featuring stock message boards, ratings, research, and strategies. Get the hottest stocks to trade every day before the market opens 100% free. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. Nasdaq 100. And so with BCRX crossing above that average target price of $11.78/share, investors in BCRX have been given a good signal to spend fresh time assessing the company and deciding for themselves: is $11.78 just one stop on the way to an even higher target, or has the valuation gotten stretched to the point where it is time to think about taking some chips off the table? $12.68. The options have an exercise price of $7.45 per share, which is equal to the closing price of BioCryst common stock on the grant date. And then on the other side of the spectrum one analyst has a target as high as $16.00. Best Crypto Stocks To Buy Right Now As Bitcoin (BTC) Breached $60K? The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. BNK Invest Inc. provides investment services and information. When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. BioCryst's antiviral drug RAPIVAB was approved by FDA in Dec 2014. $11.095. BioCryst Pharmaceuticals' stock is trading down $0.47 today. Kostenlose Echtzeit-Kurse und aktive Aktienmarkt-Foren. $11.095. View real-time stock prices and stock quotes for a full financial overview. Call Option for BioCryst Pharmaceuticals Inc. BCRX#A1521E800000. BioCryst to Host Virtual R&D Day on March 22, 2021. BioCryst Pharmaceuticals Inc. Aktie aktuelle News Realtime Kurs & Chart Fundamentaldaten, Analysen & mehr - BioCryst Pharmaceuticals Inc. Aktie 896047, US09058V1035 You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. This article used data provided by Zacks Investment Research via Quandl.com. The summary for BIOCRYST PHARMACEUTICALS INC is based on the most popular technical indicators — Moving Averages, Oscillators and Pivots. Get the latest BioCryst Pharmaceuticals, Inc. (BCRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. BioCryst Pharmaceuticals (NASDAQ: BCRX) is a mid-cap biotechnology company that is developing medications on two main areas of focus, and has one commercialized medications. 11/03/2021 00:22:52 1 … Check the real-time BCRX stock price on the NASDAQ exchange and access historical data for BioCryst Pharmaceuticals, Inc. stock. % danach wurde die Tagessitzung bei $ 4 geschlossen. 54 – 4 am Dienstag, November 10 hinzugefügt 4. The standard deviation is $3.153. 26. Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. VAT not included. What Is BioCryst Pharmaceuticals's Net Debt? Hinweis. The all time high for this statistics is 25. These symbols will be available throughout the site during your session. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level. The stock had previously closed at $11.10. Free forex prices, toplists, indices and lots more. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … Free forex prices, toplists, indices and lots more. The company traded as high as $12.31 and last traded at $12.07. Biocryst Pharmaceuticals. stock was originally listed at a price of $7.00 in Dec 31, 1997. lll BioCryst Pharmaceuticals PUSH-Chart | Push-Chartanalysen aktuelle Performance jetzt in Realtime einfach und schnell bei ariva.de ansehen. There are 9 different analyst targets contributing to that average for BioCryst Pharmaceuticals Inc, but the average is just that — a mathematical average. © 2021, Nasdaq, Inc. All Rights Reserved. BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) announced today the pricing of an underwritten public offering of 18,711,113 shares of its common stock, offered at a price to the public of $4.50 per share. Ausführliches Aktienporträt der BioCryst Pharmaceuticals - WKN 896047, ISIN US09058V1035 - bei finanztreff.de topaktuell! When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. Free forex prices, toplists, indices and lots more. Type a symbol or company name. Analyst reaction may also depend on the fundamental business developments that may be responsible for driving the stock price higher — if things are looking up for the company, perhaps it is time for that target price to be raised. As you can see below, BioCryst Pharmaceuticals had US$80.6m of debt, at June 2020, which is about the same as the year before. Approximately 6,345,274 shares changed hands during mid-day trading, a decline of 11% from the average daily volume of 7,123,782 shares. Biocryst Pharmaceuticals Aktie (BCRX) Branche: : (WKN: 896047 ISIN: US09058V1035 ) Kurs mit Realtime Chart Alle Entwicklungen, Kommentare und News auf BörsenNEWS.de live verfolgen. Real-time exchange rate quote of BioCryst Pharmaceuticals, Inc. including detailed information, live chart and news, profile and other market data. BioCryst Pharmaceuticals Reaches Analyst Target Price, Didn't Get Your Second Stimulus Check? BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. BioCryst Pharmaceuticals (NASDAQ:BCRX) had its price target raised by stock analysts at JPMorgan Chase & Co. from $10.00 to $15.00 in a report issued on Wednesday, The Fly reports. To short BioCryst Pharmaceuticals stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Data is currently not available. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. Get the latest Zacks research report on BCRX — FREE. BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares, dropped in value on Thursday, Feb 04, with the stock price down by -6.31% to the previous day’s close as weak demand from buyers trailed the stock to $9.65. BioCryst Pharmaceuticals (NASDAQ:BCRX) last posted its quarterly earnings results on Wednesday, February 24th. Auf dieser Seite erhalten Sie Realtimekurse für Nasdaq 100 -Werte (Bid/Ask) in Dollar (Bats Realtime Indikation). Get BioCryst Pharmaceuticals Inc (BCRX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Data is currently not available. Outsmart the market with Smart Portfolio analytical tools powered by TipRanks. It has also been approved in Japan, Korea and China The company was founded in 1986 by Charles E. Bugg, Ph.D. and John A. Montgomery, Ph.D. Investors in BioCryst Pharmaceuticals Inc (Symbol: BCRX) saw new options become available this week, for the May 21st expiration. JPMorgan Chase & Co.'s price objective indicates a potential upside of 18.20% from the stock's current price. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.23-1.77%: 12.76: 00:00:07: Open Price Low Price High Price Close Price Prev Close; 12.87: 12.30: 13.16: 12.64: 12.99: more quote information » Recent News. BioCryst Pharmaceuticals (BCRX) stock price, charts, trades & the US's most popular discussion forums. The program will cover BioCryst’s unique, proven and prolific approach to developing oral medicines for rare diseases, with a focus on BCX9930, an oral … The brokerage presently has an "overweight" rating on the biotechnology company's stock. Das Volumen addierte 8, 414, 830 Aktien, die mit dem durchschnittlichen Volumen von 8 verglichen werden. for only. BioCryst Pharmaceuticals Aktie: Hier finden Sie den BioCryst Pharmaceuticals Aktienkurs aktuell und ausserdem weitere Informationen wie den BioCryst Pharmaceuticals Chart Free forex prices, toplists, indices and lots more. There are analysts with lower targets than the average, including one looking for a price of $7.00. (NASDAQ: BCRX) Biocryst Pharmaceuticals currently has 176,565,622 outstanding shares. RESEARCH TRIANGLE PARK, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today … Free trial. But the whole reason to look at the average BCRX price target in the first place is to tap into a "wisdom of crowds" effort, putting together the contributions of all the individual minds who contributed to the ultimate number, as opposed to what just one particular expert believes. © 2021, Nasdaq, Inc. All Rights Reserved. ATX 3 158 0,3% DAX 14 502 -0,5% Dow 32 779 0,9% EStoxx50 3 833 -0,3% Nasdaq 12 937 -0,9% Öl 69,2 -0,6% Euro 1,1954 -0,3% CHF 1,1109 0,3% Gold 1 727 0,2% The largest stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) was held by Baker Bros. Advisors, which reported holding $21.9 million worth … Type a symbol or company name. BioCryst Pharmaceuticals had a negative net margin of 233.45% and a negative return on equity of 328.70%. The two main areas that BioCrysts works in are the anti-viral space and the complement space. BioCryst Pharmaceuticals has a 52 week low of $1.58 and a 52 week high of $12.90. With Biocryst Pharmaceuticals stock trading at $12.64 per share, the total value of Biocryst Pharmaceuticals stock (market capitalization) is $2.23B. These symbols will be available throughout the site during your session. Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB. Short sellers are betting that BioCryst Pharmaceuticals will decline in price. Monthly Subscription. BNK Invest caters to investing firms and individual investors internationally. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Recently, BioCryst … BioCryst (NASDAQ:BCRX) develops novel, oral and small molecules that inhibit enzymes playing a key role in biological pathways of rare diseases. RBLX Stock Price: How High Will Roblox Stock Go? Source: NASDAQ Stocks, Symbol: BioCryst Pharmaceuticals, Inc. 26-20:27 GMT. Realtime-Chart und Realtime-Kurs für die BioCryst Pharmaceuticals Aktie auf BÖRSE ONLINE. %, der Ausblick über die letzten fünf Tage waren rot. BioCryst Pharmaceuticals Inc: BCRX: NASDAQ: Common Stock Price Change Change Percent Stock Price Last Traded -0.67-4.97%: 12.81: 15:18:33: Open Price Low Price High Price Close Price Prev Close; 13.50: 12.63: 13.75: 13.48: Support 1 Support 2 Pivot Price Resistance 1 Resistance 2; 12.3767 : 11.9433 : 13.0633 : 13.4967 : 14.1833 : more quote information » BCRX Chart. BioCryst Pharmaceuticals Aktie und BCRX Kursdiagramme. The biotechnology company reported ($0.34) EPS for the quarter, missing the consensus estimate of ($0.25) by ($0.09). Nasdaq 100. BioCryst Pharmaceuticals, Inc. Common Stock (BCRX) Nasdaq Listed. Nasdaq 100. Stay up to date with the latest discoveries, events, and reports from BioCryst. The currently approved medication for BioCryst is peramivir, which we will discuss further in this piece. (BCRX) Nasdaq Listed. BioCryst Pharmaceuticals (NASDAQ:BCRX) last released its quarterly earnings data on Wednesday, February 24th. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. BioCryst Pharmaceuticals Aktie - Hier finden Sie: BioCryst Pharmaceuticals Aktienkurs aktuell, Kurs, Chart und alle Kennzahlen für die BioCryst Pharmaceuticals Aktie. BioCryst Pharmaceuticals, Inc. Common Stock. BioCryst to Host Virtual R&D Day on March 22, 2021. BCRX | Complete BioCryst Pharmaceuticals Inc. stock news by MarketWatch. Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) rose 8.7% during mid-day trading on Tuesday . Latest Share Price and Events Stable Share Price : BCRX is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 16% a week. Here's What to Do. If you had invested in Biocryst Pharmaceuticals stock at …